EMD-11312

Helical reconstruction
3.6 Å
EMD-11312 Deposition: 06/07/2020
Map released: 07/07/2021
Last modified: 01/05/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-11312

Structure of the Shigella MxiH needle filament attached to the basal body

EMD-11312

Helical reconstruction
3.6 Å
EMD-11312 Deposition: 06/07/2020
Map released: 07/07/2021
Last modified: 01/05/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Shigella flexneri 5a str. M90T
Sample: Needle filament of the type III secretion system
Fitted models: 6zni (Avg. Q-score: 0.46)

Deposition Authors: Lunelli M, Kotov V
Helical reconstruction of Salmonella and Shigella needle filaments attached to type 3 basal bodies.
Kotov V, Lunelli M, Wald J , Kolbe M, Marlovits TC
(2021) Biochem Biophys Rep , 27 , 101039 - 101039
PUBMED: 34258394
DOI: doi:10.1016/j.bbrep.2021.101039
ISSN: 2405-5808
Abstract:
Gram-negative pathogens evolved a syringe-like nanomachine, termed type 3 secretion system, to deliver protein effectors into the cytoplasm of host cells. An essential component of this system is a long helical needle filament that protrudes from the bacterial surface and connects the cytoplasms of the bacterium and the eukaryotic cell. Previous structural research was predominantly focused on reconstituted type 3 needle filaments, which lacked the biological context. In this work we introduce a facile procedure to obtain high-resolution cryo-EM structure of needle filaments attached to the basal body of type 3 secretion systems. We validate our approach by solving the structure of Salmonella PrgI filament and demonstrate its utility by obtaining the first high-resolution cryo-EM reconstruction of Shigella MxiH filament. Our work paves the way to systematic structural characterization of attached type 3 needle filaments in the context of mutagenesis studies, protein structural evolution and drug development.